On October 30, 2024, the Company completed a registered public offering of 1,181,540 shares of the Company’s common stock at $16.25 per share, generating net proceeds of approximately $17.7 million, ...
Amgen and AstraZeneca said on Friday that their asthma drug Tezspire reduced nasal congestion and the size of nasal ...
The Philadelphia Phillies recently raised close to $500 million in capital from three new investors, according to two people ...
The Federal Reserve trimmed interest rates by a quarter point, bringing the target rate range to 4.5% to 4.75%. Fed Chair ...
7h
AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...
At the close in Stockholm, the OMX Stockholm 30 lost 1.01%. The best performers of the session on the OMX Stockholm 30 were ...
Results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps showed that AstraZeneca (AZN) and ...
NEW YORK, NY / ACCESSWIRE / November 8, 2024 / Pomerantz LLP is investigating claims on behalf of investors of AstraZeneca PLC ("AstraZeneca" or the "Company") (NASDAQ:AZN). Such investors are advised ...
Hosted on MSN8h
What on earth is going on with the AstraZeneca share price?The AstraZeneca (LSE:AZN) share price just dipped below £100 per share. The stock has seriously underperformed in recent months, falling from above £130 in August. So, let’s take a look at what’s ...
U.S. President-elect Donald Trump said in a post on his Truth Social site on Friday that he has "no intention of selling" ...
Six months after Amgen and AstraZeneca reported promising results for Tezspire (tezepelumab) as a potential treatment for ...
However, prices per share can matter to investors who don't have a lot of cash to put to work. David Jagielski(AstraZeneca): One of the most magnificent stocks healthcare investors can buy for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback